Skip to main content
NACFC 2025 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session

PHARM
Session Type: Thematic Poster Session

TPS01--Pharmacotherapy

Thursday, October 23, 2025
10:15 AM - 11:45 AM PDT
Location:Theater A Exhibit Hall

Presentations:

  • 10:15 AM - 11:45 AM PDT
    Tobramycin pharmacokinetics in pediatric people with cystic fibrosis on maintenance azithromycin

    Speaker: Rebecca S. Pettit, PharmD, MBA, BCPS, BCPPS, FCCP – Riley Hospital for Children at Indiana Unversity Health

  • 10:15 AM - 11:45 AM PDT
    Insurance approval rates and barrier to access for vanzacaftor-tezacaftor-deutivacaftor at a single pediatric CF center

    Speaker: Stephanie Duehlmeyer, PharmD, BCPPS, AE-C – Child

  • 10:15 AM - 11:45 AM PDT
    The shenanigans continue: alternative funding program evolutions and CF care

    Speaker: Theresa Alban, JD, MPH – Cystic Fibrosis Foundation

  • 10:15 AM - 11:45 AM PDT
    Implementation of Elexacaftor/Tezacaftor/Ivacaftor (ETI) Side Effect (SE) Review and Documentation for Pediatric Cystic Fibrosis (CF) Population 

    Speaker: Allison Massesy, BSN, RN, CPN – Ascension Seton SCC; Dell Children's Medical Center

  • 10:15 AM - 11:45 AM PDT
    Elexacaftor/tezacaftor/ivacaftor concentrations in pediatric cystic fibrosis patients on modified dosing regimens

    Speaker: Cameron J. McKinzie, PharmD, BCPPS, BCPS, CPP – UNC Medical Center

  • 10:15 AM - 11:45 AM PDT
    Dose optimization of omadacycline for the treatment of NTM pulmonary disease using a PBPK modeling approach

    Speaker: Madeline Sanders, BS – University of Southern California

  • 10:15 AM - 11:45 AM PDT
    Bridging Gaps in Access: Prior Authorization Challenges in CFTR Modulator Therapies. A Quality improvement Project

    Speaker: Ryan Juel, MS, RD, LD, CACFD – WVU Medicine

  • 10:15 AM - 11:45 AM PDT
    Pregnancy-related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in cystic fibrosis women

    Speaker: Paulette Magnas, n/a – aU1343, Pharmacologie et évaluations thérapeutiques chez l'enfant et la femme enceinte, Inserm, Université Paris Cité, Paris (France)

  • 10:15 AM - 11:45 AM PDT
    The waiting game: Exploring deferred CFTR modulator initiation in pediatric cystic fibrosis care

    Speaker: Nour Kadouh, PharmD, BCPPS – University of Michigan

  • 10:15 AM - 11:45 AM PDT
    Increasing CF Ambulatory Pharmacist Support using a Shared Specialty Position  

    Speaker: Jena Jastrow, PharmD – Children's Wisconsin